Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Studies on the substrate specificity of Escherichia coli galactokinase.

Yang J, Fu X, Jia Q, Shen J, Biggins JB, Jiang J, Zhao J, Schmidt JJ, Wang PG, Thorson JS.

Org Lett. 2003 Jun 26;5(13):2223-6.

PMID:
12816414
2.

Structure-based engineering of E. coli galactokinase as a first step toward in vivo glycorandomization.

Yang J, Fu X, Liao J, Liu L, Thorson JS.

Chem Biol. 2005 Jun;12(6):657-64.

3.

Substrate specificity and mechanism from the structure of Pyrococcus furiosus galactokinase.

Hartley A, Glynn SE, Barynin V, Baker PJ, Sedelnikova SE, Verhees C, de Geus D, van der Oost J, Timson DJ, Reece RJ, Rice DW.

J Mol Biol. 2004 Mar 19;337(2):387-98.

PMID:
15003454
4.

Functional studies of rat galactokinase.

Chu X, Li N, Liu X, Li D.

J Biotechnol. 2009 May 20;141(3-4):142-6. doi: 10.1016/j.jbiotec.2009.03.003. Epub 2009 Mar 25.

PMID:
19433218
5.

A highly efficient galactokinase from Bifidobacterium infantis with broad substrate specificity.

Li L, Liu Y, Wang W, Cheng J, Zhao W, Wang P.

Carbohydr Res. 2012 Jul 1;355:35-9. doi: 10.1016/j.carres.2012.04.022. Epub 2012 May 8.

PMID:
22633137
6.

Sugar recognition by human galactokinase.

Timson DJ, Reece RJ.

BMC Biochem. 2003 Nov 4;4:16.

7.

Creation of the first anomeric D/L-sugar kinase by means of directed evolution.

Hoffmeister D, Yang J, Liu L, Thorson JS.

Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13184-9.

8.

Wide sugar substrate specificity of galactokinase from Streptococcus pneumoniae TIGR4.

Chen M, Chen LL, Zou Y, Xue M, Liang M, Jin L, Guan WY, Shen J, Wang W, Wang L, Liu J, Wang PG.

Carbohydr Res. 2011 Nov 8;346(15):2421-5. doi: 10.1016/j.carres.2011.08.014. Epub 2011 Aug 22.

PMID:
21903203
9.
10.

Galactokinase: structure, function and role in type II galactosemia.

Holden HM, Thoden JB, Timson DJ, Reece RJ.

Cell Mol Life Sci. 2004 Oct;61(19-20):2471-84. Review.

PMID:
15526155
11.

The molecular architecture of human N-acetylgalactosamine kinase.

Thoden JB, Holden HM.

J Biol Chem. 2005 Sep 23;280(38):32784-91. Epub 2005 Jul 8.

12.

A heterologous substrate assay for the HIV-1 protease engineered in Escherichia coli.

Stebbins J, Deckman IC, Richardson SB, Debouck C.

Anal Biochem. 1996 Nov 1;242(1):90-4.

PMID:
8923970
13.
14.

Substrate specificity of galactokinase from Streptococcus pneumoniae TIGR4 towards galactose, glucose, and their derivatives.

Zou Y, Wang W, Cai L, Chen L, Xue M, Zhang X, Shen J, Chen M.

Bioorg Med Chem Lett. 2012 May 15;22(10):3540-3. doi: 10.1016/j.bmcl.2012.03.095. Epub 2012 Apr 3.

PMID:
22513283
15.

Mechanistic implications of Escherichia coli galactokinase structure-based engineering.

Hoffmeister D, Thorson JS.

Chembiochem. 2004 Jul 5;5(7):989-92. No abstract available.

PMID:
15239057
16.

Increased promiscuity of human galactokinase following alteration of a single amino acid residue distant from the active site.

Kristiansson H, Timson DJ.

Chembiochem. 2011 Sep 5;12(13):2081-7. doi: 10.1002/cbic.201100308. Epub 2011 Jul 11.

PMID:
21748839
17.

Substrate specificity of NovM: implications for novobiocin biosynthesis and glycorandomization.

Albermann C, Soriano A, Jiang J, Vollmer H, Biggins JB, Barton WA, Lesniak J, Nikolov DB, Thorson JS.

Org Lett. 2003 Mar 20;5(6):933-6.

PMID:
12633109
18.

Static and dynamic interactions between GALK enzyme and known inhibitors: guidelines to design new drugs for galactosemic patients.

Chiappori F, Merelli I, Milanesi L, Marabotti A.

Eur J Med Chem. 2013 May;63:423-34. doi: 10.1016/j.ejmech.2013.02.021. Epub 2013 Feb 27.

PMID:
23517731
19.

A one-pot enzymatic approach to the O-fluoroglucoside of N-methylanthranilate.

Caputi L, Rejzek M, Louveau T, O'Neill EC, Hill L, Osbourn A, Field RA.

Bioorg Med Chem. 2013 Aug 15;21(16):4762-7. doi: 10.1016/j.bmc.2013.05.057. Epub 2013 Jun 5.

20.

Supplemental Content

Support Center